FDA, CDC Reopen Investigation of Salmonella in Moringa Leaf Powder

The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), in collaboration with state and local partners, have reopened a multistate outbreak investigation of Salmonella Typhimurium and Salmonella Newport infections linked to recalled dietary supplements containing imported moringa leaf powder due to the addition of new cases and exposure information.

Since the investigation was closed on March 17, 22 new illnesses from four states have been reported. As of May 27, 119 people infected with one of the outbreak strains of Salmonella have been reported from 36 states since the investigation began.

Whole genome sequencing (WGS) showed that bacteria from sick people’s samples are closely related genetically. Illnesses started on dates ranging from August 22, 2025, to April 26, 2026. Of 109 people with information available, 32 have been hospitalized. No deaths have been reported.

Of the 79 people interviewed, including some of the 22 new cases, 70 (89%) reported eating a product containing moringa leaf powder, including 60 who reported Live it Up Super Greens supplement powders only, five who reported Why Not Natural moringa powder capsules only, one person who reported consuming both Live it Up Super Greens powder and Why Not Natural capsules, and four who reported TNVitamins moringa powder capsules only, said FDA.

On May 26, Total Nutrition Inc. of Deer Park, N.Y., recalled:

• Tnvitamins-brand Ultra Potent Complete Green Superfood Moringa capsules 10,000 mg (120 capsules) lot 2507199 EXP 09/2027, lot 2512-304 EXP 02/2028, and lot 2793 EXP 02/2028
• Doctor’s Pride Complete Green Superfood Ultra Potent Moringa 10,000 mg (120 capsules) Lot: 2507199 Exp. 09/2027

FDA said it is conducting additional traceback of the supply chain to identify the source of the outbreak. The agency is working with state and local partners to sample products and determine if additional products may be contaminated.